Evidence map›Paper›PMID 35773408›Full record

ArticleScientific reports2022

Impaired differentiation potential of CD34-positive cells derived from mouse hair follicles after long-term culture.

Yukiteru Ouji, Masayasu Misu, Tomotaka Kitamura, Daisuke Okuzaki, Masahide Yoshikawa

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Yukiteru OujiDepartment of Pathogen, Infection and Immunity, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, 634-8521, Japan. oujix@naramed-u.ac.jp.
Masayasu MisuDepartment of Pathogen, Infection and Immunity, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, 634-8521, Japan.
Tomotaka KitamuraDepartment of Pathogen, Infection and Immunity, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, 634-8521, Japan.
Daisuke OkuzakiGenome Information Research Center, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan.
Masahide YoshikawaDepartment of Pathogen, Infection and Immunity, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, 634-8521, Japan.
Nara Medical University · JPThe University of Osaka · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hair follicle epithelial stem cells (HFSCs), which exist in the bulge region, have important functions for homeostasis of skin as well as hair follicle morphogenesis. Although several methods for isolation of HFSCs using a variety of stem cell markers have been reported, few investigations regarding culture methods or techniques to yield long-term maintenance of HFSCs in vitro have been conducted. In the present study, we screened different types of commercially available culture medium for culturing HFSCs. Among those tested, one type was shown capable of supporting the expression of stem cell markers in cultured HFSCs. However, both the differentiation potential and in vivo hair follicle-inducing ability of HFSCs serially passaged using that optimal medium were found to be impaired, probably because of altered responsiveness to Wnt signaling. The changes noted in HFSCs subjected to a long-term culture suggested that the Wnt signaling-related environment must be finely controlled for maintenance of the cells.

Indexed as

Hair FollicleStem CellsAnimalsAntigens, CD34Cell DifferentiationCells, CulturedMiceAntigens, CD34

Identifiers

PMID35773408
PMCPMC9247072
OpenAlexW4283764616

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.